Biotech ETF Rises 17% in a Month Without NVIDIA
A biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
Explore blue-chip coin candidates beyond BTC/ETH and how they fit into a balanced, long-term strategy with clear evaluation criteria.
24,967 articlesA biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
The head of the Virtual Assets Regulatory Authority warns that the sector’s AI-driven future will advance only as fas...
A new poll finds 89% of registered voters backing the main provisions of the ROAD Act, even as the bill remains stall...
Phantom’s strategic pivot toward leveraged derivatives signals a new era for Solana users. This guide unpacks what it...
By mid-2026, the Bitcoin mining pool landscape shows a widening divide. The top four pools control roughly 70% of has...
PepsiCo trims snack prices in North America to spur demand, but the pause in regional growth keeps investors focused ...
Gold miners ETFs are in focus as 2026's rally tests the resilience of senior producers versus junior explorers. This ...
NVIDIA is at the center of the AI hardware boom, fueling bets that the stock will climb to new highs by 2027. Analyst...
Mega-cap tech now drives most S&P 500 gains, leaving the rest of the market with thinner support. Here’s what investo...
If you’re wondering what the next year holds for stocks, this guide stays grounded. It blends data, real-world exampl...
As Apple eyes a leadership transition, analysts debate whether Apple stock will outpace the S&P 500 in the new CEO’s ...
California's new EV incentive is tilting the playing field for Rivian and Tesla. With Q1 results out, investors are w...